Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Corvus Pharmaceuticals (CRVS): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
8 analysts
Options Flow (P/C)
0.00
More calls — Bullish
Avg Consensus PT
$29
+185.5%
Highest Price Target
$42
+315.4%
Lowest Price Target
$11
+8.8%
Short Interest
23.9%
Declining — Bullish
Insider Activity (30d)
Net Buyer
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Apr 17, 2026 | Goldman Sachs | Paul Choi— | +295.6% | $40 | Initiate | Buy |
| Mar 13, 2026 | Oppenheimer | Jeff Jones— | +226.4% | $32 → $33 | Maintained | Outperform |